SM
PGNX
Sabby Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-174,900
| Closed | -$738K | – | 231 |
|
|
2016
Q2 | $738K | Sell |
174,900
-170,297
| -49% | -$719K | 0.04% | 94 |
|
|
2016
Q1 | $1.51M | Buy |
+345,197
| New | +$1.51M | 0.08% | 63 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 230 |
|
|
2015
Q3 | – | Sell |
-247,706
| Closed | -$1.85M | – | 252 |
|
|
2015
Q2 | $1.85M | Sell |
247,706
-371,694
| -60% | -$2.77M | 0.07% | 62 |
|
|
2015
Q1 | $3.7M | Buy |
619,400
+555,401
| +868% | +$3.32M | 0.15% | 28 |
|
|
2014
Q4 | $484 | Buy |
+63,999
| New | +$484 | 0.02% | 84 |
|
|
2014
Q3 | – | Sell |
-365,186
| Closed | -$1.57M | – | 170 |
|
|
2014
Q2 | $1.57M | Sell |
365,186
-152,608
| -29% | -$658K | 0.07% | 42 |
|
|
2014
Q1 | $2.12M | Buy |
+517,794
| New | +$2.12M | 0.12% | 33 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 136 |
|